Analyst Price Target is $16.77
▲ +43.70% Upside Potential
This price target is based on 13 analysts offering 12 month price targets for Health Catalyst in the last 3 months. The average price target is $16.77, with a high forecast of $39.00 and a low forecast of $8.00. The average price target represents a 43.70% upside from the last price of $11.67.
Current Consensus is
The current consensus among 13 polled investment analysts is to buy stock in Health Catalyst. This Buy consensus rating has held steady for over two years.
Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology, and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in South Jordan, UT.